Bonifazi F, Pavoni C, Peccatori J, Giglio F, et al. Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01. Bone Marrow Transplant 2022 Apr 12. pii: 10.1038/s41409-022-01626.
PMID: 35413985